2026-01-09 01:23:24

AbbVie (ABBV) has denied ongoing merger negotiations with Revolution Medicines (RVMD), contradicting recent reports from major financial media outlets suggesting the two biotech firms were nearing a deal. The denial comes as market participants digest competing signals about potential consolidation in the cancer therapeutics sector. Investors are closely watching how this develops, given the significant implications for both companies' stock valuations and their oncology pipelines.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

11 Likes

Reward
11
7
Repost
Share

Comment

0/400

RooftopVIP

· 01-10 15:00

Starting to shift blame again, a typical "talk first, deny later" tactic.

View OriginalReply0

NewPumpamentals

· 01-09 01:38

Fake news again, these financial media outlets are really outrageous.

View OriginalReply0

P2ENotWorking

· 01-09 01:35

It's the same story again, saying there was no negotiation without actually negotiating? The media already exposed it earlier, and now denying it makes it even more suspicious.

View OriginalReply0

airdrop_huntress

· 01-09 01:32

They're starting to debunk rumors again. Why does this routine feel so familiar?

View OriginalReply0

GateUser-7b078580

· 01-09 01:31

Data shows that this denial statement is a classic signal... When counting these reversals on an hourly basis, although the stock price has already been driven up once. Observing the pattern, these sensational news releases are all paving the way for subsequent actions. Let's wait a bit longer; unreasonable mechanisms will eventually be exposed.

View OriginalReply0

tokenomics_truther